Calls Grow to Ease Biotech Listing Rules in China and Hong Kong as Healthcare Investment Gains Momentum

Calls Grow to Ease Biotech Listing Rules in China and Hong Kong as Healthcare Investment Gains Momentum

  • March 5, 2026

China and Hong Kong are being encouraged to relax listing requirements for biotechnology companies as investors seek to accelerate growth in the healthcare sector. Venture capital leaders and industry participants argue that regulatory adjustments could help innovative biotech firms gain faster access to

China Steps Up Funding for AI Driven Drugmakers in Push for Biotech Self Reliance

China Steps Up Funding for AI Driven Drugmakers in Push for Biotech Self Reliance

  • February 11, 2026

China is accelerating financial support for artificial intelligence driven drug developers as part of a broader national strategy to strengthen technological self reliance in critical sectors. State backed investment funds are channeling capital into biotech firms that combine advanced computing with pharmaceutical research,